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Assessment of the efficacyofreperfusion strategiesforacute 
myocardial infarction has frequently focused on the restora- 
tion of angiographic patency of the infarct-related artery, 
with intuitive acce@ancc @the principle that ctical benefit 
with this form of therapy is linked to the establishment of an 
open vessel. The Thmmtdysis in Myocardial Infarction 
(TIM11 study group (I) initially proposed the criteria by 
which angiographic patency after thromholysis is qualita- 
tively classified according to the extent of penetration of 
radiographic contrast medium beyond a coronary lesion: 
grade 0 (no Bow). grade 1 (minimal penetration of contrast 
medium), grade 2 (delayed Row of contrast medium that flls 
the infarct anev) and grade 3 (brisk and complete filling of 
the infarct vessel). By convention, arteries with TIMI grade 
0 or I flow have been regarded es occluded, and those 
exhibiting grade 2 or 3 Raw have been considered to be 
patent, despite the absence of correlative clinical or myocar- 
dial salvage data to support the functional equivalence of 
TIM1 grades 2 and 3 flow. 
Recent investigations have in fact challenged the premise 
that the establishment of TIMI grade 2 Sow represents 
effective recanalization of the infarct-related vessel. Two 
repells (2.3) have associated the presence of grade 2 flow 
with an increased risk for reocclusion of the infarct artcry in 
small groups of patients. In an analysis of the Second 
Multicenter Thrombolysis Trial of Eminase in Acute Myo- 
cardial Infarction (TEAM-Z), data comparing anistreplase 
with streptokinase (4), indexes of infarct size (serum cardiac 
snryme peaks, time to peak cardiac enzyme levels, and 
evolution of summed electrocardiographic [ECGI segments) 
in patients with TIM1 grade 2 flow at angiogrepky W to 
240 min after thrombolysis were compat-eble te those of 
patients with TIM1 grade 0 or 1 flow but significantly inferior 
to indexes in patients exhibiting TIM1 grade 3 perfusion. 
Although regional and global left ventricular function were 
not directly measured in this study, these data suggested that 
myocardial salvage in the presence of TIM1 grade 2 Row may 
be no better than with an occluded infarct ariery. 
The present study. In this issue of the Journal, Vogt et al. 
(5) seek to establish whether early perfusion status of the 
infarct-related vessel is a valid surrogate end point for 
clinical outcome after thrombolytic therapy. In doing so, 
they meaningfully extend previous investigations of the 
functional adequacy of TIM1 grade 2 flow by focusing on 
mortality, the most fundanien*&t clinical end point. Among 
this large cohort of patients prospectively enrolled in four 
German multicenter randomized thrombolytic trials, TiMJ 
grade 2 rather than grade 3 Row at ‘XXmin angiogmphy 
proved to be i significant predictor of substantially higher 
risk for in-hosphal death (6.6% vs. 2.7%): it is imp+ltant that 
the motity rate among patients with TIMI grade 2 flow 
was essentially the same as that in patients with occluded 
(TIM1 grade 0 or I Row) infarct-related arteries (7.1%). The 
association between TIM1 Row and mortality in this patient 
group was not confounded by the choice of thmmbolytic 
agent or the use of adjunctive acute coronary angiaplesty. 
These findings by Vogt et al. (5) have been corroborated 
by recent preliminary reports by two other groups of inves- 
timtom. Among ~1,200 patients enmlled in five phases of 
the Tbombolysis and Anaioplesty in Myocardial Infarction 
(TAMI) trials (61, TIMi grade 2 rather than grade 3 Row after 
reperfuoion therapy was associated with a graater risk for 
development of recurrent ischemia IX congestive heart fail- 
ure, diminished salvage of regional and global left ventricular 
function and a trend toward a higher mortality rate (10.1%, 
6.1% or 4.3% among patients with TIM1 grade WI, 2 or 3 
Row. rerpsstively). The TIM1 study group (7) examined 154 
patients who underwent angiogmphy at 90 min and Ig to 36 h 
after thrombolysiq in the TIMI- trial and observed that 
patients v&h TIM1 grade 2 flow had a threefold greater risk 
of raocclusion than that of patients wilh grade 3 flow (IS% 
vs. &). 
ti grade 2 Row: cause or &et? Taken togelher with 
the findings of the TEAM-2 (4). TAM1 (6). and TIMI (7) 
study groups, the present analysis by Vogt and ass&ales (5) 
provides compelling evidence that the patient with TIMI 
grade 2 rather than complete TIM1 grade 3 Row after 
thrombelysis is at excess risk with respect to nearly every 
major clinical end point and salvage of left ventricular 
function. What remains unclear is whether TIM1 grade 2 
tlow is a cause or simply a marker of adverse ou1come. 
Incomplete oatcncv with TIM1 made 2 flow. whether due to 
severe.rasidiel stekosis, a critical but angiographically inap- 
parent thrombus burden, increased va.omotor arterial tone 
or distal embolization of thrombin and platelet-fibrin aggre- 
gates from the ruptured atherosclerotic plaque, may be 
inadequate to sustain myocrudial viability, thereby resulting 
in less myocardial salvage. Alternatively, distal TlMI grade 
2 blood flow observed by angiography after thrombolysis 
may simply Lx a conssquence of more extensive myocaniial 
necrosis and edema and represent a relative no-&our ph& 
nomenen. The existence of this lack of reflow phenomenon 
was elegantly demonstrated in humans in a recent report by 
ho and associates (8). It! their study. myocardial cootrast 
echocardiography revealed an absence of tissue level p&u- 
sion in 23% of 39 patients with successful recanalhation of 
the infarct-rebated artery after tnrombolysis for anterior 
myocardial infarction. and the presence of a residual 
echocardiographic contrast defect was associated with 
markedly diminished recovery of global and regional left 
ventricular function. 
Interpretation of the clinical relevance of TIM1 grade 2 
Row after reperfosioa therapy is fwtber complicated by the 
limitations of a static W-min anpiwranhic view of corooarv 
patency. It is likely tiiat the &up bf patients exhibiting 
TIM1 grade 2 flow at any instant in time is heterogeneous. 
encompassing a spectrum of those in whom perfusion of the 
infarct-related artery is improving along the continuum 10 
TIM1 grade 3 Row. as well as patients with exrensive 
myocardiat necrosis or edema or unstable lesions prone to 
reocclusion. These different patient subsets, whose prog- 
noses would be expected io be substantially dissimilar, 
may be distinguishable by newr technologies wirh en- 
hanced abilities to assess the stability and tree extent of 
reperfusion, such as conlmst perfusion echocard.iography or 
wminuous U-lead di&Jl electrocardiography. Krucoff et 
al. (91, for example, have shown in a prospective study that 
the findings of ST segment recovery analysis are actually 
consistent with infarct vessel pelency rather than occlusion 
in SO% of patients witb TIM1 grade 2 tlow at7er thrombo- 
lytic therapy. 
lmplieatioos for optimal reperfusioa. According to the 
iraditianal definition encompassing both TIM1 grade 2 and 
grade 3 Row, patency of the infarct-related vessel will be 
restored by 90 min after initiation of therapy with front- 
loaded regimens of tissue plasminogen activator (t-PA) in 
~85% of patients with acute myocardial infarction. This 
seemingly impressive accomplishment has led to a sense of 
complacency at having attained the ceiling of patency with 
thrombolytic strategies. It is apparent. however, that T!MI 
grades? and 3 How are not equivalent in this setting and the 
achievement of grade 2 reflow does not constitute optimal 
repelfusion. The relative frequency of grade ! and 3 flow in 
coronary arteries considered 10 be patent after infarction has 
been remarkably consistent in different repcms (Table I). 
Among 412 padents in three randomized t&s undergoing 
angiognphy within 90 min rAei therapy with rapid dosing of 
t-PA (IO-I?). 70% (range 62% to 78%) and 15% (range 12% 
to 20%) were found to have TV.41 wade 3 and erade 2 flow. 
respectively. The frequency of TIM1 grade 3 flow has been 
subarantially lower after treatment with other thrombolytic 
regimens (range 47% to 62%). 
An even more sobering erosion oithromtwtytic efticacy is 
evident s hen other factors such as early reocclusinn are also 
considered. The authors of the present study (5) recently 
reported a related analysis of the same patient cohon (13) in 
which on/y 54.7% oJpdents were believed to have achieved 
optimal thrombolysis of the infarct-related artery with t-PA, 
anistreplase. wokinase or recombinant plasmiaogen activa- 
tor by the criterion ofTIM grde 3 flow at 90 min without 
reocclusion on follow-up aogiography 24 10 48 h later. There 
clearly exists, then. a oick!!; dc%n phenomenon of levels of
coronary patency after thmmtulysis for acute myocardiat 
infarction. with the majority of patients failing to achieve 
oodmal reeertiision as orwressiveb more rigorous but rel- 
&ant criteria are applied. _ 
Coochisioos. The invest&ion bv Voat et al. (5) hiah- 
lights the deficiency oiinm~plete &ow&d the decep&e 
nature ofa simple angiognphic patency measorement for the 
assessroem of lhrombolytic etlicacy. Complacency with the 
state of the XI of rep&&n therapy is in Let not war- 
ranted. and continued &Torts will be reqwred 10 recognize 
and swmoum the inadequacies of presen: methodologies. 
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